CTLA4 and cancer: In immunotherapy of cancer, the use of blocking anti–CTLA-4 and anti–PD-1 antibodies have yielded promising results, and the 2018 Nobel Prize was granted to Jim P. Allison and Tasuku Honjo, who are the pioneers in this field (Wolchok, 2018).